CEVAZURIL 50 mg/mL Oral suspension for piglets
Nchi: Hispania
Lugha: Kiingereza
Chanzo: HMA (Heads of Medicines Agencies)
Tabia za bidhaa
(SPC)
07-03-2013
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
toltrazuril 50 mg/ml
Inapatikana kutoka:
CEVA Santé Animale
ATC kanuni:
QP51AJ01
Dawa fomu:
Oral suspension
Kundi la matibabu:
toltrazuril
Eneo la matibabu:
Pigs Young
Idhini ya tarehe:
2012-02-13
Tabia za bidhaa
1/4
Dokument1
Jan. 09
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
CEVAZURIL 50 mg/ml, oral suspension for piglets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Toltrazuril ........................... 50.0 mg
EXCIPIENTS:
Sodium benzoate (E211)......... 2.1 mg
Sodium propionate (E281) ...... 2.1 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension.
White homogeneous suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Piglets.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention of clinical signs of coccidiosis in neonatal piglets on farms with a confirmed history
of coccidiosis caused by Isospora suis.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
It is recommended to treat all piglets in a litter.
Hygienic measures may reduce the risk of porcine coccidiosis. It is therefore, recommended to
improve concomitantly the hygienic conditions in the concerned facility, particularly dryness and
cleanliness.
To alter the course of an established clinical coccidial infection, in individual animals already showing
signs of diarrhoea, additional supportive therapy may be required.
As with any antiparasiticide, frequent and repeated use of antiprotozoals from the same class may lead
to the development of resistance.
2/4
Dokument1
Jan. 09
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None known.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO
ANIMALS
Soma hati kamili
